Literature DB >> 16306232

Heme deficiency is associated with senescence and causes suppression of N-methyl-D-aspartate receptor subunits expression in primary cortical neurons.

Tatyana Chernova1, Pierluigi Nicotera, Andrew G Smith.   

Abstract

Heme is a crucial component of many pharmacological and toxicological processes, and studies have suggested that heme deficiency may play a role in cellular ageing. A model of ageing neurons was established using prolonged cultures of BALB/c mouse primary cortical neurons. Aged neurons displayed a senescent phenotype and a marked up-regulation of cathepsin-L expression. Down-regulation of the candidate neuron-specific genes for N-methyl-D-aspartate (NMDA) receptor subunits (NMDAzeta1 and -epsilon2) and neurofilament light peptide (NF-L) were found to be characteristic of the aging process as reported in vivo (Brain Res 907:71-83, 2001; Brain Res Mol Brain Res 99:40-45, 2002). In contrast, the genes for the controlling enzymes of heme synthesis and degradation (5-aminolevulinate synthase 1 and heme oxygenase 1, respectively) were up-regulated, implying depletion of a regulatory heme pool. Inhibition of heme synthesis (by 70-80%) at different enzymic steps by succinyl acetone and N-methylprotoporphyrin IX resulted in the earlier lowered expression of NMDAzeta1 and -epsilon2 and NF-L. Exogenous hemin added to heme-depleted cells rescued the expression of these neuron-specific genes. Culture of cortical neurons from BALB/c Fech(m1Pas) mutant mice demonstrating depressed heme synthesis showed premature senescence and reduced expression of NMDAzeta1 and -epsilon2 receptor subunits and NF-L compared with wild-type cells. Our findings suggest that reduced availability of heme in neurons associated with senescence may have significant effects on synaptic function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16306232     DOI: 10.1124/mol.105.016675

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  28 in total

1.  Disordered porphyrin metabolism: a potential biological marker for autism risk assessment.

Authors:  Nicholas J Heyer; Diana Echeverria; James S Woods
Journal:  Autism Res       Date:  2012-02-01       Impact factor: 5.216

2.  Influence of Iron Deficiency on Olfactory Behavior in Weanling Rats.

Authors:  V M Ruvin Kumara; Marianne Wessling-Resnick
Journal:  J Behav Brain Sci       Date:  2012

Review 3.  Mitochondria at the neuronal presynapse in health and disease.

Authors:  Michael J Devine; Josef T Kittler
Journal:  Nat Rev Neurosci       Date:  2018-01-19       Impact factor: 34.870

4.  Integrating multiple aspects of mitochondrial dynamics in neurons: age-related differences and dynamic changes in a chronic rotenone model.

Authors:  Beth Arnold; Steven J Cassady; Victor S VanLaar; Sarah B Berman
Journal:  Neurobiol Dis       Date:  2010-09-17       Impact factor: 5.996

Review 5.  Cerebroprotective functions of HO-2.

Authors:  Helena Parfenova; Charles W Leffler
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

6.  Aging of the NMDA receptor: from a mouse's point of view.

Authors:  Kathy R Magnusson
Journal:  Future Neurol       Date:  2012-09

Review 7.  Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders.

Authors:  P J Syapin
Journal:  Br J Pharmacol       Date:  2008-09-15       Impact factor: 8.739

8.  Analysis of the genes coding for subunit 10 and 15 of cytochrome c oxidase in Alzheimer's disease.

Authors:  Massimiliano Vitali; Eliana Venturelli; Daniela Galimberti; Luisa Benerini Gatta; Elio Scarpini; Dario Finazzi
Journal:  J Neural Transm (Vienna)       Date:  2009-10-14       Impact factor: 3.575

9.  Genetic polymorphisms affecting susceptibility to mercury neurotoxicity in children: summary findings from the Casa Pia Children's Amalgam clinical trial.

Authors:  James S Woods; Nicholas J Heyer; Joan E Russo; Michael D Martin; Federico M Farin
Journal:  Neurotoxicology       Date:  2014-08-07       Impact factor: 4.294

10.  Down-regulation of aminolevulinate synthase, the rate-limiting enzyme for heme biosynthesis in Alzheimer's disease.

Authors:  Barney E Dwyer; Mark A Smith; Sandy L Richardson; George Perry; Xiongwei Zhu
Journal:  Neurosci Lett       Date:  2009-05-27       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.